IP Library Granted Patent US 9,572,694
Granted Patent B2
US 9,572,694 · App. 14/256,604 · Granted Feb 21, 2017

Helical graft

Inventors: Colin G. Caro (London, GB); Nicholas V. Watkins (London, GB); Spencer J. Sherwin (London, GB)
Assignee: Veryan Medical Limited
A61F2/915A61F2/06A61F2002/068A61F2002/91508A61F2002/91516B29C53/14B29C65/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,572,694
App. No.
14/256,604
Granted
Feb 21, 2017
Kind
B2
Abstract

A graft includes a flow tubing having a tubing portion defining a flow lumen. The flow lumen of the tubing portion is substantially free of ribs or grooves. A center line of the flow lumen follows a substantially helical path with a helix angle less than or equal to 65°. The amplitude of the helix is less than or equal to one half of the internal diameter of the tubing portion.

Claims (19)

1. A method of inhibiting flow instability in a graft for biomedical use, the graft comprising flow tubing which is for use in vivo to carry blood and which is made of biocompatible material, the flow tubing having a tubing portion with an internal diameter and defining a flow lumen, wherein the flow lumen of the tubing portion is of circular cross-section, the flow lumen of said tubing portion having a centre line and being substantially free of ribs or grooves, wherein the graft is thermally set such that it retains a twisted shape and the centre line of the flow lumen follows a helical path about a longitudinal axis so as to define a helical center line, the helical center line having a helix angle and a helix amplitude, the helix angle being less than or equal to 45°, and the helix amplitude being less than or equal to one half of the internal diameter of the tubing portion, and wherein the flow tubing is flexible and is capable of adopting a configuration in which the longitudinal axis is curved and the helical center line of the tubing portion follows a helical path about the curved longitudinal axis.

2. A method as claimed in claim 1 , wherein the amplitude of the helical center line divided by the internal diameter of the tubing is at least 0.05.

3. A method as claimed in claim 1 , wherein the helix angle is less than or equal to 15°.

4. A method as claimed in claim 1 , wherein the centre line of the tubing portion follows a substantially helical path about an axis which is curved.

5. A method as claimed in claim 1 , wherein the graft further comprises a pharmaceutical coating.

6. A method as claimed in claim 1 , wherein the tubing portion comprises a tubular wall which resists reduction of the amplitude of the helical centre line.

7. A method as claimed in claim 1 , wherein the graft is thermally shape set.

8. A method as claimed in claim 1 , wherein the tubing portion has a wall comprising a helical winding to help maintain a circular cross-section of the flow lumen.

9. A method as claimed in claim 8 , wherein the helix angle of the helical winding is larger than the helix angle of the helical centre line of the flow lumen.

10. A method as claimed in claim 1 , wherein the graft comprises ePTFE.

11. A method of inhibiting flow instability in a graft for biomedical use, the graft comprising flow tubing which is for use in vivo to carry blood and which is made of biocompatible material, the flow tubing having a tubing portion with an internal diameter and defining a flow lumen, wherein the flow lumen of the tubing portion is of circular cross-section, wherein the graft is thermally set such that it retains a twisted shape and the center line of the flow lumen follows a helical path about a longitudinal axis so as to define a helical center line, the helical center line having a helix angle and, a helix amplitude, the helix angle being less than or equal to 45°, the helix amplitude being less than or equal to one half of the internal diameter of the tubing portion, and the amplitude of the helical centre line divided by the internal diameter of the tubing portion is at least 0.05, and wherein the flow tubing is flexible and is capable of adopting a configuration in which the longitudinal axis is curved and the helical center line of the tubing portion follows a helical path about the curved longitudinal axis.

12. A method as claimed in claim 11 , wherein the helix angle is less than or equal to 15°.

13. A method as claimed in claim 11 , wherein the center line of the tubing portion follows a substantially helical path about an axis which is curved.

14. A method as claimed in claim 11 , wherein the graft further comprises a pharmaceutical coating.

15. A method as claimed in claim 11 wherein the tubing portion comprises a tubular wall which resists reduction of the amplitude of the helical center line.

16. A method as claimed in claim 11 , wherein the graft is thermally shape set.

17. A method as claimed in claim 11 , wherein the tubing portion has a wall comprising a helical winding to help maintain a circular cross-section of the flow lumen.

18. A method as claimed in claim 11 , wherein the helix angle of the helical winding is larger than the helix angle of the helical center line of the flow lumen.

19. A method as claimed in claim 11 , wherein the graft comprises ePTFE.

Assignments (2)
SECURITY INTEREST Recorded Jan 27, 2017
From: VERYAN MEDICAL LIMITED
To: SILICON VALLEY BANK
Reel/Frame 041519/0685 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2014
From: CARO, COLIN G.; WATKINS, NICHOLAS V.; SHERWIN, SPENCER J.
To: VERYAN MEDICAL LIMITED
Reel/Frame 032710/0564 →
Priority Claims (4)
GB 0306176.9 · Mar 18, 2003 · national
GB 0317004.0 · Jul 21, 2003 · national
GB 0321327.9 · Sep 11, 2003 · national
GB 0328757.0 · Dec 11, 2003 · national
Continuity (2)
Division 10549498
Related Publication 20140225304A1 · Aug 14, 2014